Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats

被引:0
作者
Almomen, Aliyah [1 ]
Maher, Hadir M. [2 ]
Alzoman, Nourah Z. [1 ]
Shehata, Shereen M. [1 ]
Alsubaie, Amal [3 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
[2] Alexandria Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Alexandria, Egypt
[3] Saudi Food & Drug Author, Biol Prod Evaluat Directorate, Riyadh, Saudi Arabia
关键词
Flavored water; Tyrosin Kinase Inhibitors; Erlotinib; Gefitinib; Pharmacokinetic; Rat; Drug interaction; Toxicity; In vivo; UPLC; TYROSINE KINASE INHIBITORS; P-GLYCOPROTEIN INHIBITORS; PRIMARY HUMAN HEPATOCYTES; GRAPEFRUIT JUICE; CRANBERRY JUICE; CLINICAL PHARMACOKINETICS; FRUIT JUICES; LUNG-CANCER; IN-VITRO; DRUG;
D O I
10.7717/pearj.9881
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Erlotinib (ERL) and gefitinib (GEF) are considered first line therapy for the management of non-small cell lung carcinoma (NSCLC). Like other tyrosine kinase inhibitors (TKIs), ERL and GEF are mainly metabolized by the cytochrome P450 (CYP450) CYP3A4 isoform and are substrates for transporter proteins with marked inter-/intra-individual pharmacokinetic (PK) variability. Therefore, ERL and GEF are candidates for drug-drug and food-drug interactions with a consequent effect on drug exposure and/or drug-related toxicities. In recent years, the consumption of flavoured water (FW) has gained in popularity. Among multiple ingredients, fruit extracts, which might constitute bioactive flavonoids, can possess an inhibitory effect on the CYP450 enzymes or transporter proteins. Therefore, in this study we investigated the effects of different types of FW on the PK parameters of ERL and GEF in Wistar rats. Methods. ERL and GEF PK parameters in different groups of rats after four weeks consumption of different flavours of FW, namely berry, peach, lime, and pineapple, were determined from plasma drug concentrations using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results. Data indicated that tested FWs altered the PK parameters of both ERL and GEF differently. Lime water had the highest impact on most of ERL and GEF PK parameters, with a significant increase in C-max. (95% for ERL, 58% for GEF), AUC(0-48) (111% for ERL, 203% for GEF), and AUC(0-infinity), (200% for ERL, 203% for GEF), along with a significant decrease in the apparent oral clearance of both drugs (65% for ERL, 67% for GEF). The order by which FW affected the PK parameters for ERL and GEF was as follows: lime > pineapple > berry > peach. Conclusion. The present study indicates that drinking FW could be of significance in rats receiving ERL or GEF. Our results indicate that the alteration in PKs was mostly recorded with lime, resulting in an enhanced bioavailability, and reduced apparent oral clearance of the drugs. Peach FW had a minimum effect on the PK parameters of ERL and no significant effect on GEF PKs. Accordingly, it might be of clinical importance to evaluate the PK parameters of ERL and GEF in human subjects who consume FW while receiving therapy.
引用
收藏
页数:18
相关论文
共 64 条
[1]   P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review [J].
Abdallah, Hossam M. ;
Al-Abd, Ahmed M. ;
El-Dine, Riham Salah ;
El-Halawany, Ali M. .
JOURNAL OF ADVANCED RESEARCH, 2015, 6 (01) :45-62
[2]   Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux [J].
Agarwal, Sagar ;
Sane, Ramola ;
Gallardo, Jose L. ;
Ohlfest, John R. ;
Elmquist, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :147-155
[3]  
Amadi C, 2018, INT RES J PHARM, V9, P17
[4]   Fruit juice inhibition of uptake transport: a new type of food-drug interaction [J].
Bailey, David G. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (05) :645-655
[5]   Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice [J].
Bailey, DG ;
Dresser, GK ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :529-537
[6]   Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy [J].
Bansal, Tripta ;
Jaggi, Manu ;
Khar, Roop K. ;
Talegaonkar, Sushama .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2009, 12 (01) :46-78
[7]   Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography [J].
Bauer, Martin ;
Matsuda, Akihiro ;
Wulkersdorfer, Beatrix ;
Philippe, Cecile ;
Traxl, Alexander ;
Ozvegy-Laczka, Csilla ;
Stanek, Johann ;
Nics, Lukas ;
Klebermass, Eva-Maria ;
Poschner, Stefan ;
Jaeger, Walter ;
Patik, Izabel ;
Bakos, Eva ;
Szakacs, Gergely ;
Wadsak, Wolfgang ;
Hacker, Marcus ;
Zeitlinger, Markus ;
Langer, Oliver .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (01) :139-147
[8]   Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents [J].
Beretta, Giovanni Luca ;
Cassinelli, Giuliana ;
Pennati, Marzia ;
Zuco, Valentina ;
Gatti, Laura .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 142 :271-289
[9]  
Bethune Gillian, 2010, J Thorac Dis, V2, P48
[10]  
Bilek Maciej, 2014, Rocz Panstw Zakl Hig, V65, P193